Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Fischman A. J. Positron emission tomography in the clinical evaluation of metastatic cancer. J Clin Oncol. 1996 Mar;14(3):691–696. doi: 10.1200/JCO.1996.14.3.691. [DOI] [PubMed] [Google Scholar]
- Flanagan F. L., Dehdashti F., Ogunbiyi O. A., Kodner I. J., Siegel B. A. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg. 1998 Mar;227(3):319–323. doi: 10.1097/00000658-199803000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gallagher B. M., Fowler J. S., Gutterson N. I., MacGregor R. R., Wan C. N., Wolf A. P. Metabolic trapping as a principle of oradiopharmaceutical design: some factors resposible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose. J Nucl Med. 1978 Oct;19(10):1154–1161. [PubMed] [Google Scholar]
- Gupta N., Bradfield H. Role of positron emission tomography scanning in evaluating gastrointestinal neoplasms. Semin Nucl Med. 1996 Jan;26(1):65–73. doi: 10.1016/s0001-2998(96)80017-1. [DOI] [PubMed] [Google Scholar]
- Hoh C. K., Schiepers C., Seltzer M. A., Gambhir S. S., Silverman D. H., Czernin J., Maddahi J., Phelps M. E. PET in oncology: will it replace the other modalities? Semin Nucl Med. 1997 Apr;27(2):94–106. doi: 10.1016/s0001-2998(97)80042-6. [DOI] [PubMed] [Google Scholar]
- Kissel J., Brix G., Bellemann M. E., Strauss L. G., Dimitrakopoulou-Strauss A., Port R., Haberkorn U., Lorenz W. J. Pharmacokinetic analysis of 5-[18F]fluorouracil tissue concentrations measured with positron emission tomography in patients with liver metastases from colorectal adenocarcinoma. Cancer Res. 1997 Aug 15;57(16):3415–3423. [PubMed] [Google Scholar]
- Park C. H. The role of radioisotopes in radiation oncology. Semin Oncol. 1997 Dec;24(6):639–654. [PubMed] [Google Scholar]
- Phelps M. E., Huang S. C., Hoffman E. J., Selin C., Sokoloff L., Kuhl D. E. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol. 1979 Nov;6(5):371–388. doi: 10.1002/ana.410060502. [DOI] [PubMed] [Google Scholar]
- Phelps M. E., Huang S. C., Hoffman E. J., Selin C., Sokoloff L., Kuhl D. E. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol. 1979 Nov;6(5):371–388. doi: 10.1002/ana.410060502. [DOI] [PubMed] [Google Scholar]
- Sokoloff L., Reivich M., Kennedy C., Des Rosiers M. H., Patlak C. S., Pettigrew K. D., Sakurada O., Shinohara M. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 1977 May;28(5):897–916. doi: 10.1111/j.1471-4159.1977.tb10649.x. [DOI] [PubMed] [Google Scholar]
- Tempero M., Brand R., Holdeman K., Matamoros A. New imaging techniques in colorectal cancer. Semin Oncol. 1995 Oct;22(5):448–471. [PubMed] [Google Scholar]
- Thoeni R. F. Colorectal cancer. Radiologic staging. Radiol Clin North Am. 1997 Mar;35(2):457–485. [PubMed] [Google Scholar]